Medically ill Patient Assessment of Rivaroxaban versus Placebo in Reducing Post-Discharge Venous Thrombo-Embolism RISK (MARINER)
Clinical Trial Grant
Administered By
Neurology, Neurocritical Care
Awarded By
Janssen Research & Development, LLC
Start Date
September 1, 2014
End Date
August 2, 2016
Administered By
Neurology, Neurocritical Care
Awarded By
Janssen Research & Development, LLC
Start Date
September 1, 2014
End Date
August 2, 2016